EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cardiac Output and Oxygen Delivery Responses to Sotatercept in Pulmonary Arterial Hypertension

Graham Stockdale iD, Adriano R Tonelli iD, Alice Goyanes, Matthew T Siuba iD, Pradhab Kirupaharan iD, Neal F Chaisson iD, Kristin Highland iD, Joseph Parambil, Yifan Wang iD, Gustavo Heresi iD, Samar Farha iD

Pulmonary Circulation · 2026-10 · 16 (4)

DOI: 10.1002/pul2.70454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pulmonary Circulation, online erschienen am 12.11.2026. Verfasst von Graham Stockdale und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine Integrated Hospital-Care Institute, Cleveland Clinic Cleveland Ohio USA. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sotatercept, a first‐in‐class activin signaling inhibitor, improves pulmonary vascular hemodynamics and clinical outcomes in pulmonary arterial hypertension (PAH). However, despite reductions in mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR), cardiac output (CO) does not generally increase, and some patients experience a decline in CO, a finding of unclear clinical significance. We sought to characterize the heterogeneity of CO responses to sotatercept in PAH and to determine whether incorporating oxygen delivery (DO 2 ) provides additional insight into the physiological significance of these changes. We retrospectively analyzed PAH patients who underwent right heart catheterization before and during sotatercept therapy (median 7.3 months, IQR 4.8, 9.3). Hemodynamic, echocardiographic, hematologic, and clinical parameters were collected, including functional class, 6‐min walk distance (6MWD) and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP). Patients were dichotomized by CO response (decreased vs. maintained), and DO 2 was calculated at each catheterization. A total of 56 patients were included. While most demonstrated reductions in PVR and mPAP, 63% experienced decreased CO. Improvements in 6MWD and NT‐proBNP were similar between groups, and hemoglobin increased comparably. However, among patients with decreased CO, 63% had a concomitant decline in DO 2 accompanied by worsening 6MWD and a reduced NT‐proBNP response. In this real‐world cohort, over half of sotatercept‐treated PAH patients experienced reduced CO despite overall hemodynamic and clinical improvement. Concomitant reductions in DO 2 identify a subgroup with worse functional outcomes. These findings suggest that DO 2 adds additional information beyond CO alone when assessing the physiological response to sotatercept.

Schlagwörter

Stichwörter der Autor:innen

cardiac outputhemodynamicsoxygen deliverypulmonary arterial hypertensionsotatercept

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine Integrated Hospital-Care Institute, Cleveland Clinic Cleveland Ohio USA.
  • Department of Inflammation and Immunity Cleveland Clinic Research, Cleveland Clinic Cleveland Ohio USA.
  • Department of Quantitative Health Sciences Lerner Research Institute, Cleveland Clinic Cleveland Ohio USA.

ORCID-Profile: Graham Stockdale, Adriano R Tonelli, Matthew T Siuba, Pradhab Kirupaharan, Neal F Chaisson, Kristin Highland, Yifan Wang, Gustavo Heresi, Samar Farha

Zitieren

APA

Stockdale, G., Tonelli, A. R., Goyanes, A., Siuba, M. T., Kirupaharan, P., Chaisson, N. F., Highland, K., Parambil, J., Wang, Y., Heresi, G., & Farha, S. (2026). Cardiac Output and Oxygen Delivery Responses to Sotatercept in Pulmonary Arterial Hypertension. Pulmonary Circulation, 16(4). https://doi.org/10.1002/pul2.70454

Vancouver

Stockdale G, Tonelli AR, Goyanes A, Siuba MT, Kirupaharan P, Chaisson NF, et al. Cardiac Output and Oxygen Delivery Responses to Sotatercept in Pulmonary Arterial Hypertension. Pulmonary Circulation. 2026;16(4). doi:10.1002/pul2.70454

BibTeX
@article{Stockdale2026,
  author = {Stockdale, Graham and Tonelli, Adriano R and Goyanes, Alice and Siuba, Matthew T and Kirupaharan, Pradhab and Chaisson, Neal F and Highland, Kristin and Parambil, Joseph and Wang, Yifan and Heresi, Gustavo and Farha, Samar},
  title = {Cardiac Output and Oxygen Delivery Responses to Sotatercept in Pulmonary Arterial Hypertension},
  journal = {Pulmonary Circulation},
  year = {2026},
  volume = {16},
  number = {4},
  doi = {10.1002/pul2.70454}
}
Kostenlos starten →